ISRCTN13327255
Completed
Not Applicable
Medical Research Council Acute Lymphoblastic Leukaemia Trial in Children UKALL R1
Medical Research Council (MRC) (UK)0 sites256 target enrollmentAugust 19, 2002
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- eukaemia (acute)
- Sponsor
- Medical Research Council (MRC) (UK)
- Enrollment
- 256
- Status
- Completed
- Last Updated
- 11 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •1\. Children under the age of 25 years at original diagnosis with first relapse of ALL at any site from previous UKALL trials or pilot studies
- •2\. Multiple relapsed patients are excluded
- •3\. Patients with prior history of toxicity or organ damage such that completion of the protocol is felt unlikely at the outset are to be excluded
- •4\. Patients with Central Nervous System (CNS) relapse must have had prior radiotherapy
Exclusion Criteria
- •Not provided at time of registration.
Outcomes
Primary Outcomes
Not specified
Similar Trials
Completed
Not Applicable
Medical Research Council Adult Acute Lymphoblastic Leukaemia Trial UKALL XAeukaemia (acute)CancerLymphoid leukaemiaISRCTN35362654Medical Research Council (MRC) (UK)618
Completed
Not Applicable
KALL R2 - Acute Lymphoblastic Leukaemia trialAcute Lymphoblastic LeukaemiaCancerISRCTN95257778Medical Research Council (MRC) (UK)200
Completed
Not Applicable
MRC ALL 97 - UK national lymphoblastic leukaemia (ALL) trialeukaemiaCancerLymphoblastic leukaemiaISRCTN26727615Medical Research Council (MRC) (UK)1,800
Active, not recruiting
Not Applicable
AML LI1Acute myeloid leukemia and high-risk myelodysplastic syndromeMedDRA version: 17.1Level: SOCClassification code 10005329Term: Blood and lymphatic system disordersSystem Organ Class: 10005329 - Blood and lymphatic system disordersEUCTR2011-000749-19-DKCardiff University1,000
Completed
Not Applicable
Acute lymphoblastic leukaemia (ALL) trial XII (joint trial with Eastern Co-operative Oncology Group - E2993)eukaemiaCancerLeukaemiaISRCTN77346223Medical Research Council (MRC) (UK)550